TATE JEFFREY

CIK 00014990751 companyHIGH SPRINGS, FL

SEC Profile

Transactions

Companies

Filings

CIK

0001499075

Recent Transactions

33 trades

Award
Cyclo Therapeutics, Inc.
Stock Option (Right to Buy)
2024-06-03+110,732→ 110,732 total
Exercise of In-Money
Cyclo Therapeutics, Inc.
Warrant to Purchase Common Stock
2023-10-20$0.13/sh−29,941→ 0 total
Exercise of In-Money
Cyclo Therapeutics, Inc.
Common Stock
2023-10-20$0.71/sh+29,941→ 92,042 total
Purchase
Cyclo Therapeutics, Inc.
Warrant to Purchase Common Stock
2023-10-20+32,935→ 32,935 total
Purchase
Cyclo Therapeutics, Inc.
Warrant to Purchase Common Stock
2023-04-20$0.13/sh+29,941→ 29,941 total
Purchase
Cyclo Therapeutics, Inc.
Common Stock
2023-04-20$0.71/sh+29,941→ 62,101 total
Award
Cyclo Therapeutics, Inc.
Stock Option (Right to buy)
2023-03-07+41,036→ 41,036 total
Purchase
Cyclo Therapeutics, Inc.
Common Stock
2022-05-16$2.12/sh+3,000→ 32,160 total
Purchase
Cyclo Therapeutics, Inc.
Common Stock
2022-04-29$2.71/sh+1,065→ 29,160 total
Purchase
Cyclo Therapeutics, Inc.
Common Stock
2022-04-29$2.70/sh+300→ 28,095 total
Purchase
Cyclo Therapeutics, Inc.
Common Stock
2022-04-28$2.50/sh+635→ 27,795 total
Award
Cyclo Therapeutics, Inc.
Stock Options (Right to buy)
2022-02-28+31,141→ 31,141 total
Award
Cyclo Therapeutics, Inc.
Stock Option (Right to buy)
2021-08-27+23,800→ 23,800 total
Purchase
Cyclo Therapeutics, Inc.
Common Stock
2021-03-29$7.50/sh+2,000→ 27,160 total
Award
Cyclo Therapeutics, Inc.
Common Stock
2021-01-13+10,000→ 25,160 total
Award
Cyclo Therapeutics, Inc.
Common Stock
2020-12-11+5,000→ 15,160 total
Purchase
Cyclo Therapeutics, Inc.
Warrant to Purchase Common Stock
2020-12-11+5,000→ 5,000 total
Award
Cyclo Therapeutics, Inc.
Common Stock
2020-04-24$0.10/sh+50,000→ 1,015,972 total
Award
Cyclo Therapeutics, Inc.
Common Stock
2019-09-27+100,000→ 965,972 total
Purchase
Cyclo Therapeutics, Inc.
Common Stock
2018-12-26+25,000→ 865,972 total
Purchase
Cyclo Therapeutics, Inc.
Warrant to Purchase Common Stock
2018-12-26+25,000→ 25,000 total
Conversion
Cyclo Therapeutics, Inc.
Series B Convertible Preferred Stock
2018-05-23−250→ 0 total
Conversion
Cyclo Therapeutics, Inc.
Common Stock
2018-05-23+100,000→ 840,972 total
Award
Cyclo Therapeutics, Inc.
Common Stock
2018-02-01+20,000→ 740,972 total
Purchase
Cyclo Therapeutics, Inc.
Series B Convertible Preferred Stock
2017-10-18+250→ 250 total
Purchase
Cyclo Therapeutics, Inc.
Warrant to Purchase Common Stock
2017-10-18+100,000→ 100,000 total
Award
Cyclo Therapeutics, Inc.
Common Stock
2017-06-30+20,000→ 720,972 total
Award
Cyclo Therapeutics, Inc.
Common Stock
2017-03-31+20,000→ 700,972 total
Award
Cyclo Therapeutics, Inc.
Common Stock
2016-07-22+20,000→ 680,972 total
Purchase
Cyclo Therapeutics, Inc.
Common Stock
2016-06-06+100,000→ 660,972 total
Purchase
Cyclo Therapeutics, Inc.
Warrant to Purchase Common Stock
2016-06-06+100,000→ 100,000 total
Award
Cyclo Therapeutics, Inc.
Common Stock
2014-11-07+20,000→ 560,972 total
Award
Cyclo Therapeutics, Inc.
Common Stock
2014-08-01+100,000→ 540,972 total

Companies

Cyclo Therapeutics, Inc.
Director

Recent Filings

Address

C/O CTD HOLDINGS, INC. 27317 NW 78TH AVENUE

HIGH SPRINGS, FL, 32643

View on SEC.gov